Spontaneously Evolved Progenitor Niches Escape Yap Oncogene Addiction in Advanced Pancreatic Ductal Adenocarcinomas

Overview

Journal Nat Commun

Specialty Biology

Date 2023 Mar 16

PMID 36922511

Authors

Shigekazu Murakami

Shannon M White

Alec T McIntosh

Chan D K Nguyen

Chunling Yi

Affiliations

Soon will be listed here.

Abstract

Lineage plasticity has been proposed as a major source of intratumoral heterogeneity and therapeutic resistance. Here, by employing an inducible genetic engineered mouse model, we illustrate that lineage plasticity enables advanced Pancreatic Ductal Adenocarcinoma (PDAC) tumors to develop spontaneous relapse following elimination of the central oncogenic driver - Yap. Transcriptomic and immunohistochemistry analysis of a large panel of PDAC tumors reveals that within high-grade tumors, small niches of PDAC cells gradually evolve to re-activate pluripotent transcription factors (PTFs), which lessen their dependency on Yap. Comprehensive Cut&Tag analysis demonstrate that although acquisition of PTF expression is coupled with the process of epithelial-to-mesenchymal transition (EMT), PTFs form a core transcriptional regulatory circuitry (CRC) with Jun to overcome Yap dependency, which is distinct from the classic TGFb-induced EMT-TF network. A chemical-genetic screen and follow-up functional studies establish Brd4 as an epigenetic gatekeeper for the PTF-Jun CRC, and strong synergy between BET and Yap inhibitors in blocking PDAC growth.

Citing Articles

Enhancer reprogramming: critical roles in cancer and promising therapeutic strategies.

Yang J, Zhou F, Luo X, Fang Y, Wang X, Liu X Cell Death Discov. 2025; 11(1):84.

PMID: 40032852 PMC: 11876437. DOI: 10.1038/s41420-025-02366-3.

Epigenetic control of pancreatic cancer metastasis.

Krauss L, Schneider C, Hessmann E, Saur D, Schneider G Cancer Metastasis Rev. 2023; 42(4):1113-1131.

PMID: 37659057 PMC: 10713713. DOI: 10.1007/s10555-023-10132-z.

References

Kardon D, Thompson L, Przygodzki R, Heffess C . Adenosquamous carcinoma of the pancreas: a clinicopathologic series of 25 cases. Mod Pathol. 2001; 14(5):443-51. DOI: 10.1038/modpathol.3880332. View

Tchernitsa O, Sers C, Zuber J, Hinzmann B, Grips M, Schramme A . Transcriptional basis of KRAS oncogene-mediated cellular transformation in ovarian epithelial cells. Oncogene. 2004; 23(26):4536-55. DOI: 10.1038/sj.onc.1207585. View

Shao D, Xue W, Krall E, Bhutkar A, Piccioni F, Wang X . KRAS and YAP1 converge to regulate EMT and tumor survival. Cell. 2014; 158(1):171-84. PMC: 4110062. DOI: 10.1016/j.cell.2014.06.004. View

Kato H, Tateishi K, Fujiwara H, Nakatsuka T, Yamamoto K, Kudo Y . MNX1-HNF1B Axis Is Indispensable for Intraductal Papillary Mucinous Neoplasm Lineages. Gastroenterology. 2021; 162(4):1272-1287.e16. DOI: 10.1053/j.gastro.2021.12.254. View

Lin L, Sabnis A, Chan E, Olivas V, Cade L, Pazarentzos E . The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies. Nat Genet. 2015; 47(3):250-6. PMC: 4930244. DOI: 10.1038/ng.3218. View

Gruber R, Panayiotou R, Nye E, Spencer-Dene B, Stamp G, Behrens A . YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK-STAT3 Signaling. Gastroenterology. 2016; 151(3):526-39. PMC: 5007286. DOI: 10.1053/j.gastro.2016.05.006. View

Zanconato F, Forcato M, Battilana G, Azzolin L, Quaranta E, Bodega B . Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth. Nat Cell Biol. 2015; 17(9):1218-27. PMC: 6186417. DOI: 10.1038/ncb3216. View

Weinstein I . Cancer. Addiction to oncogenes--the Achilles heal of cancer. Science. 2002; 297(5578):63-4. DOI: 10.1126/science.1073096. View

Boeva V, Louis-Brennetot C, Peltier A, Durand S, Pierre-Eugene C, Raynal V . Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries. Nat Genet. 2017; 49(9):1408-1413. DOI: 10.1038/ng.3921. View

10.

Yohe M, Gryder B, Shern J, Song Y, Chou H, Sindiri S . MEK inhibition induces MYOG and remodels super-enhancers in RAS-driven rhabdomyosarcoma. Sci Transl Med. 2018; 10(448). PMC: 8054766. DOI: 10.1126/scitranslmed.aan4470. View

11.

Ramirez F, Ryan D, Gruning B, Bhardwaj V, Kilpert F, Richter A . deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 2016; 44(W1):W160-5. PMC: 4987876. DOI: 10.1093/nar/gkw257. View

12.

Jiang Y, Jiang Y, Li C, Zhang Y, Dakle P, Kaur H . TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines. Gastroenterology. 2020; 159(4):1311-1327.e19. DOI: 10.1053/j.gastro.2020.06.050. View

13.

Naka H, Nakamura S, Shimazaki T, Okano H . Requirement for COUP-TFI and II in the temporal specification of neural stem cells in CNS development. Nat Neurosci. 2009; 11(9):1014-23. DOI: 10.1038/nn.2168. View

14.

Chen Y, Xu L, Mayakonda A, Huang M, Kanojia D, Tan T . Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma. Nat Commun. 2019; 10(1):1353. PMC: 6430783. DOI: 10.1038/s41467-019-09257-z. View

15.

Francies H, McDermott U, Garnett M . Genomics-guided pre-clinical development of cancer therapies. Nat Cancer. 2022; 1(5):482-492. DOI: 10.1038/s43018-020-0067-x. View

16.

Eser S, Reiff N, Messer M, Seidler B, Gottschalk K, Dobler M . Selective requirement of PI3K/PDK1 signaling for Kras oncogene-driven pancreatic cell plasticity and cancer. Cancer Cell. 2013; 23(3):406-20. DOI: 10.1016/j.ccr.2013.01.023. View

17.

Liu X, Li H, Rajurkar M, Li Q, Cotton J, Ou J . Tead and AP1 Coordinate Transcription and Motility. Cell Rep. 2016; 14(5):1169-1180. PMC: 4749442. DOI: 10.1016/j.celrep.2015.12.104. View

18.

Kapoor A, Yao W, Ying H, Hua S, Liewen A, Wang Q . Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer. Cell. 2014; 158(1):185-197. PMC: 4109295. DOI: 10.1016/j.cell.2014.06.003. View

19.

Neph S, Stergachis A, Reynolds A, Sandstrom R, Borenstein E, Stamatoyannopoulos J . Circuitry and dynamics of human transcription factor regulatory networks. Cell. 2012; 150(6):1274-86. PMC: 3679407. DOI: 10.1016/j.cell.2012.04.040. View

20.

Boyer L, Lee T, Cole M, Johnstone S, Levine S, Zucker J . Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 2005; 122(6):947-56. PMC: 3006442. DOI: 10.1016/j.cell.2005.08.020. View